Metabolic disease is a growing global concern, posing significant challenges to healthcare systems worldwide. Traditional treatment approaches often fall short in providing lasting benefits, leading to the exploration of novel therapeutic options. Recent advancements in peptide research have yielded promising candidates such as Semaglutide, exhibit